Jamese J. Hilliard

1.7k total citations
37 papers, 1.4k citations indexed

About

Jamese J. Hilliard is a scholar working on Molecular Biology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Jamese J. Hilliard has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Infectious Diseases and 9 papers in Pharmacology. Recurrent topics in Jamese J. Hilliard's work include Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Resistance in Bacteria (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Jamese J. Hilliard is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (12 papers), Antibiotic Resistance in Bacteria (7 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Jamese J. Hilliard collaborates with scholars based in United States, France and Russia. Jamese J. Hilliard's co-authors include Karen Bush, C. Kendall Stover, Christine Tkaczyk, Raúl Goldschmidt, JoAnn Suzich, Bret R. Sellman, Vivekananda Datta, Ellen Z. Baum, Lily Cheng and Ashley Keller and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Biochemistry.

In The Last Decade

Jamese J. Hilliard

37 papers receiving 1.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jamese J. Hilliard 675 491 250 180 172 37 1.4k
Jacob Poehlsgaard 839 1.2× 536 1.1× 332 1.3× 250 1.4× 90 0.5× 16 1.6k
Lykke H. Hansen 920 1.4× 438 0.9× 285 1.1× 294 1.6× 151 0.9× 34 1.6k
John Pace 459 0.7× 618 1.3× 307 1.2× 239 1.3× 179 1.0× 30 1.7k
Dmitri Debabov 620 0.9× 559 1.1× 227 0.9× 212 1.2× 217 1.3× 42 1.5k
John P. Santa Maria 834 1.2× 440 0.9× 192 0.8× 106 0.6× 141 0.8× 13 1.5k
Clara Leandro 528 0.8× 311 0.6× 240 1.0× 305 1.7× 160 0.9× 24 1.2k
Jose Antonio Reales‐Calderón 568 0.8× 421 0.9× 364 1.5× 258 1.4× 56 0.3× 26 1.3k
Sebabrata Mahapatra 705 1.0× 620 1.3× 145 0.6× 475 2.6× 168 1.0× 35 1.3k
Nagraj Mani 534 0.8× 588 1.2× 151 0.6× 309 1.7× 112 0.7× 36 1.3k
Sergio Lociuro 547 0.8× 225 0.5× 356 1.4× 133 0.7× 282 1.6× 37 1.3k

Countries citing papers authored by Jamese J. Hilliard

Since Specialization
Citations

This map shows the geographic impact of Jamese J. Hilliard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamese J. Hilliard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamese J. Hilliard more than expected).

Fields of papers citing papers by Jamese J. Hilliard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamese J. Hilliard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamese J. Hilliard. The network helps show where Jamese J. Hilliard may publish in the future.

Co-authorship network of co-authors of Jamese J. Hilliard

This figure shows the co-authorship network connecting the top 25 collaborators of Jamese J. Hilliard. A scholar is included among the top collaborators of Jamese J. Hilliard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamese J. Hilliard. Jamese J. Hilliard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakielaszek, Charles, Mohammad Sharif Hossain, Lian Qian, et al.. (2022). Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague. Science Translational Medicine. 14(647). eabg1787–eabg1787. 9 indexed citations
2.
Jones-Nelson, Omari, Jamese J. Hilliard, Antonio DiGiandomenico, et al.. (2018). The Neutrophilic Response to Pseudomonas Damages the Airway Barrier, Promoting Infection by Klebsiella pneumoniae. American Journal of Respiratory Cell and Molecular Biology. 59(6). 745–756. 12 indexed citations
3.
Cohen, Taylor S., Jamese J. Hilliard, Omari Jones-Nelson, et al.. (2016). Staphylococcus aureus α toxin potentiates opportunistic bacterial lung infections. Science Translational Medicine. 8(329). 329ra31–329ra31. 93 indexed citations
4.
DiGiandomenico, Antonio, Ashley Keller, Cuihua Gao, et al.. (2014). A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Science Translational Medicine. 6(262). 262ra155–262ra155. 215 indexed citations
5.
Grant, Eugene B., Barbara D. Foleno, Raúl Goldschmidt, et al.. (2014). 7-(4-Alkylidenylpiperidinyl)-quinolone bacterial topoisomerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(23). 5502–5506. 5 indexed citations
6.
Tkaczyk, Christine, Melissa Hamilton, Vivekananda Datta, et al.. (2013). Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model. PLoS ONE. 8(10). e75103–e75103. 69 indexed citations
7.
Fernandez, Jeffrey, et al.. (2011). Efficacy of a New Fluoroquinolone, JNJ-Q2, in Murine Models of Staphylococcus aureus and Streptococcus pneumoniae Skin, Respiratory, and Systemic Infections. Antimicrobial Agents and Chemotherapy. 55(12). 5522–5528. 15 indexed citations
8.
Zhu, Bin, Raúl Goldschmidt, Barbara D. Foleno, et al.. (2009). Synthesis and antibacterial activity of 7-(1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-7-yl) quinolones. Bioorganic & Medicinal Chemistry Letters. 19(17). 4933–4936. 19 indexed citations
9.
Fernandez, Jeffrey, Jamese J. Hilliard, Darren Abbanat, et al.. (2009). In Vivo Activity of Ceftobiprole in Murine Skin Infections Due toStaphylococcus aureusandPseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 54(1). 116–125. 13 indexed citations
10.
Tennakoon, Manomi A., Todd C. Henninger, Darren Abbanat, et al.. (2006). Synthesis and antibacterial activity of C6-carbazate ketolides. Bioorganic & Medicinal Chemistry Letters. 16(24). 6231–6235. 8 indexed citations
11.
Xu, Xiaodong, Todd C. Henninger, Darren Abbanat, et al.. (2005). Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximes. Bioorganic & Medicinal Chemistry Letters. 15(4). 883–887. 19 indexed citations
12.
Baum, Ellen Z., Steven M. Crespo‐Carbone, Barbara D. Foleno, et al.. (2005). Identification of a Dithiazoline Inhibitor of Escherichia coli l , d -Carboxypeptidase A. Antimicrobial Agents and Chemotherapy. 49(11). 4500–4507. 13 indexed citations
13.
Weidner‐Wells, Michele A., Harvey M. Werblood, Raúl Goldschmidt, et al.. (2004). The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones. Bioorganic & Medicinal Chemistry Letters. 14(12). 3069–3072. 22 indexed citations
14.
Henninger, Todd C., Xiaodong Xu, Darren Abbanat, et al.. (2004). Synthesis and antibacterial activity of C-6 carbamate ketolides, a novel series of orally active ketolide antibiotics. Bioorganic & Medicinal Chemistry Letters. 14(17). 4495–4499. 18 indexed citations
15.
Hlasta, Dennis J., James P. Demers, Barbara D. Foleno, et al.. (1998). Novel inhibitors of bacterial two-component systems with gram positive antibacterial activity: Pharmacophore identification based on the screening hit closantel. Bioorganic & Medicinal Chemistry Letters. 8(14). 1923–1928. 56 indexed citations
16.
Hilliard, Jamese J., Lee D. Simon, Laurence Van Melderen, & Michael R. Maurizi. (1998). PinA Inhibits ATP Hydrolysis and Energy-dependent Protein Degradation by Lon Protease. Journal of Biological Chemistry. 273(1). 524–527. 27 indexed citations
17.
Hilliard, Jamese J., Michael R. Maurizi, & Lee D. Simon. (1998). Isolation and Characterization of the Phage T4 PinA Protein, an Inhibitor of the ATP-dependent Lon Protease ofEscherichia coli. Journal of Biological Chemistry. 273(1). 518–523. 21 indexed citations
18.
Hilliard, Jamese J., et al.. (1995). A Comparison of Active Site Binding of 4-Quinolones and Novel Flavone Gyrase Inhibitors to DNA Gyrase. PubMed. 390. 59–69. 35 indexed citations
19.
Barrett, John F., et al.. (1993). Testing Potential Gyrase Inhibitors of Bacterial DNA Gyrase: A Comparison of the Supercoiling Inhibition Assay and "Cleavable Complex" Assay. Analytical Biochemistry. 214(1). 313–317. 29 indexed citations
20.
Fu, Kwung P., et al.. (1990). In-vivo evaluation of ofloxacin in Salmonella typhimurium infection in mice. Journal of Antimicrobial Chemotherapy. 25(2). 263–268. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacob Poehlsgaard Breakdown of academic impact, for papers by Lykke H. Hansen Breakdown of academic impact, for papers by John Pace Breakdown of academic impact, for papers by Dmitri Debabov Breakdown of academic impact, for papers by John P. Santa Maria Breakdown of academic impact, for papers by Clara Leandro Breakdown of academic impact, for papers by Jose Antonio Reales‐Calderón Breakdown of academic impact, for papers by Sebabrata Mahapatra Breakdown of academic impact, for papers by Nagraj Mani Breakdown of academic impact, for papers by Sergio Lociuro
Rankless by CCL
2026